Advanced Enzyme Tech

    ADVENZYMES
    Pharma
    ₹281.00
    Price as of 18 Nov 2026, 9:58 pm IST

    Market cap ₹3,031 Cr

    P/E
    18.57
    Day range
    ₹276.50 – ₹284.00
    52-week range
    ₹246.80 – ₹419.00
    Volume
    1.71 L
    Open
    ₹284.00
    Prev close
    ₹283.15

    Latest results · Q2 FY27(consolidated)Revenue ₹215 Cr+16.2%Profit ₹51 Cr+14.4%Margin 23.8%YoY vs the same quarter last year

    No red flags in exchange filings: no rising pledge, promoter selling, surveillance or critical filing on record.

    Research profile

    Composite 54 / 100

    Factor percentiles

    Value77
    Quality61
    Momentum30
    Low volatility48

    Derived metrics

    Earn. yield
    5.4%
    Graham no.
    ₹222.09
    vs Graham
    -21.0%
    ROE ÷ P/B
    6.0%
    12-1 mom.
    -14.0%
    Return / vol
    -0.26
    Magic Formula
    #205
    Piotroski
    4/6
    FCF yield
    3.4%
    PEG
    1.29

    Percentiles rank this stock against the other tracked stocks and change as they do. Scans describe where figures sit today. Hover a label for its definition. Not investment advice.

    Peer comparison

    All 68 in Pharma
    Largest Pharma companies tracked, with sector medians
    CompanyM-capP/EP/BROEROCEOPMD/ESales YoY
    Sun PharmaSUNPHARMA₹4.49 L Cr40.955.0314.8%21.0%29.0%0.04+11.9%
    Divi's LaboratoriesDIVISLAB₹2.93 L Cr87.1916.8816.2%22.0%43.0%0.00+35.4%
    Torrent PharmaTORNTPHARM₹1.75 L Cr77.889.6726.8%15.0%33.0%0.77+50.8%
    Apollo HospitalsAPOLLOHOSP₹1.27 L Cr56.4011.5522.6%17.0%16.0%0.77+23.0%
    Laurus LabsLAURUSLABS₹1.25 L Cr93.7219.8218.2%18.0%34.0%0.43+33.5%
    Zydus LifesciencesZYDUSLIFE₹1.20 L Cr28.724.3220.1%21.0%24.0%0.50+29.2%
    Dr. Reddy's LabsDRREDDY₹1.17 L Cr41.632.9711.6%13.0%20.0%0.19-1.5%
    Advanced Enzyme TechADVENZYMES₹3,031 Cr18.571.9111.4%14.0%34.0%0.03+16.2%
    Sector median₹24,603 Cr43.685.4615.1%17.0%24.0%0.17+22.7%

    Sector as classified in the tracked universe; medians use every tracked Pharma company, and P/E only profitable ones. Tinted figures beat the median.

    Key metrics

    P/E (TTM)
    18.9
    Price / Book
    1.89
    ROE (FY26)
    11.4%
    ROCE (latest year)
    14%
    Dividend yield
    1.90%

    Moving averages (NSE)

    20-day
    ₹272.17
    Price above
    50-day
    ₹278.31
    Price above
    200-day
    ₹308.99
    Price below

    Charts & trends

    From company filings. Amounts in ₹ crore.

    Revenue 3Y CAGR
    +11.3%
    Profit 3Y CAGR
    +18.7%
    Revenue YoY (Sep 2026)
    +16.2%
    Profit YoY (Sep 2026)
    +13.3%
    Operating margin
    34.0%
    Net margin
    23.7%

    Revenue, profit & margin - quarterly

    ₹ crore; a loss shows red. Operating margin below, same periods.

    0 Cr100 Cr200 Cr300 Cr
    • Revenue
    • Net profit

    Operating margin

    Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Sep 20260%20%40%

    Who owns the company

    % of equity by quarter, latest Sept 2026

    Dec '24Mar '25Jun '25Sept '25Dec '25Mar '26Jun '26Sept '260%25%50%75%100%
    • Promoter
    • Public
    • FII
    • DII

    Cash flows

    Where cash came from and went, by fiscal year (₹ crore)

    Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026-400 Cr-200 Cr0 Cr200 Cr
    • Operating
    • Investing
    • Financing
    • Free cash flow

    Return on equity

    Net profit over shareholders' equity, by fiscal year

    FY17FY18FY19FY20FY21FY22FY23FY24FY25FY260%10%20%30%15% screen

    Equity vs debt

    Shareholders' equity against borrowings (₹ crore); the ratio below, same years.

    0 Cr500 Cr1K Cr1.5K Cr2K Cr
    • Equity
    • Debt

    Debt to equity

    Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Sep 20260x0.5x1x

    Dividends per share

    ₹ by fiscal year of the ex-date; the latest year runs to date.

    FY20FY21FY22FY23FY24FY25FY26FY27₹0₹2₹4₹6

    Financial statements

    ₹ Crore
    Quarterly results, oldest period first, figures in rupees crore
    Line itemDec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
    Sales161158155146169167186185172203192215
    YoY Sales growth———-7————————
    Expenses107102103104114122129124123140139142
    Operating Profit545551425546566049635372
    OPM %33%35%33%29%33%27%30%33%29%31%28%34%
    Other Income14-671089910207119
    Interest111111111111
    Depreciation9999910101010101011
    Profit before tax594049425343556058605469
    Tax %28%25%28%21%27%38%26%25%26%24%28%26%
    Net Profit423035333927404543453951
    EPS in Rs₹3.74₹2.53₹3.05₹2.94₹3.37₹2.37₹3.57₹3.87₹3.80₹3.84₹3.31₹4.31

    From company filings, updated 19 Nov 2026. Consolidated figures where the company reports them. Information only, not investment advice.

    Working-capital cycle

    Debtor Days71

    +8 days since Mar 2021

    Inventory Days335

    -11 days since Mar 2021

    Days Payable76

    +20 days since Mar 2021

    Cash Conversion Cycle331

    -22 days since Mar 2021

    Working Capital Days116

    +22 days since Mar 2021

    Strengths, risks & growth

    Advanced Enzyme Technologies Limited is engaged in the business of manufacturing and sales of enzymes. [1]

    Strengths

    • Company is almost debt free.
    • Company has been maintaining a healthy dividend payout of 40.9%

    Risks

    • The company has delivered a poor sales growth of 8.24% over past five years.
    • Company has a low return on equity of 10.4% over last 3 years.

    Compounded Sales Growth

    10 Years
    +10%
    5 Years
    +8%
    3 Years
    +11%
    TTM
    +11%

    Compounded Profit Growth

    10 Years
    +7%
    5 Years
    +2%
    3 Years
    +14%
    TTM
    +10%

    Stock Price CAGR

    10 Years
    -3%
    5 Years
    -4%
    3 Years
    -4%
    1 Year
    -14%

    Return on Equity

    10 Years
    +13%
    5 Years
    +10%
    3 Years
    +10%
    Last Year
    +11%

    Strengths and risks are a machine-generated checklist, not advice; growth is compounded annually over each period.

    Shareholding pattern

    Percentage of shares held by each category at each quarter end
    HolderDec 2025Mar 2026Jun 2026Sept 2026Change
    Promoter43.04%43.26%43.25%43.56%+0.31 pp
    FII25.85%25.50%26.70%26.64%-0.06 pp
    DII5.51%5.41%4.77%1.89%-2.88 pp
    Public25.62%25.85%25.28%27.90%+2.62 pp

    Filed with NSE for Sept 2026: promoters 43.56%, public 56.44%

    Analysts & fund holdings

    100%
    100% recommend buy
    1 analysts cover the stock
    Valuation vs Chemicals
    P/E18.6 vs 25.1
    Sector P/B3.02
    Beta1.15

    Who holds the shares, quarter by quarter

    Mutual funds 1.18% (-0.64 pp)
    Jun 25
    Sept 25
    Dec 25
    Mar 26
    Jun 26
    Sept 26
    • Promoters43.6%
    • Foreign institutions26.6%
    • Mutual funds1.2%
    • Insurance0.0%
    • Other domestic institutions0.7%
    • Retail17.1%
    • Others10.8%
    Mutual funds holding the most
    Fund% of company% of fund3-month change
    UTI MNC Fund0.92%1.12%-0.11 pp
    Motilal Oswal Nifty Microcap 250 Index Fund0.12%0.15%-0.01 pp
    JioBlackRock Flexi Cap Fund0.06%0.06%-0.01 pp
    Groww Nifty Total Market Index Fund0.00%0.01%-0.00 pp
    Bandhan BSE Healthcare Index Fund0.00%0.08%-0.01 pp

    Scorecard

    Performance
    Low
    Valuation
    High
    Growth
    Low
    Profitability
    High
    Entry point
    Good
    Red flags
    Low

    Analyst coverage, holdings and scorecard from market data; not a recommendation by Rajat Finance.

    Risk & trend

    From 292 daily sessions to 18 Nov 2026.

    Computed

    Risk

    Volatility (1Y)
    37.0%
    Downside volatility
    36.5%
    Worst 5% of days
    3.4%
    Average of that tail
    5.6%
    Max drawdown (1Y)
    36.7%
    Below its peak
    28.3%

    Against the market

    Beta vs Nifty 50
    0.97
    Correlation
    0.35
    Relative strength (3M)
    -11.9%
    ATR (14)
    3.1%

    Return

    Return 1M
    +5.2%
    Return 3M
    -8.0%
    Return 6M
    -22.7%
    Return 1Y
    -9.5%
    vs 200-day average
    -9.1%

    Momentum

    RSI (14)
    54.7
    MACD histogram
    1.69
    Stochastic %K
    77.1
    ADX (14)
    27.0
    +DI / −DI
    16.8 / 13.8
    Money flow index
    69.8

    Participation

    Delivery (20d avg)
    57.0%
    vs its 60-day baseline
    -0.8 pts
    Volume vs 20-day
    -0.4σ
    Close vs day's VWAP
    +0.1%
    52-week position
    23 / 100

    These describe what this stock's price has already done. They are not forecasts, signals or recommendations, and a dash means the figure was withheld for want of enough history rather than being zero.

    Financial quality

    From consolidated statements to 30 Sept 2026.

    Computed

    Piotroski F-Score

    4 of 6 tested

    • Return on assets positive — passed
    • Operating cash flow positive — not testableno cash flow statement for this period
    • Return on assets improving — passed
    • Cash flow exceeds profit — not testableneeds cash flow and profit against assets
    • Debt to assets falling — failed
    • Current ratio improving — passed
    • No new equity issued — not testableno share count is collected, and financing cash flow mixes equity with debt
    • Operating margin improving — failed
    • Asset turnover improving — passed
    Free cash flow
    ₹104 Cr
    FCF yield
    3.4%
    Cash conversion
    0.90
    Accruals ratio
    0.009
    Net debt
    -₹105 Cr
    Net debt / equity
    -0.06
    EV / sales
    3.75
    PEG
    1.29
    Capex intensity
    7.0%
    Revenue CAGR
    18.1%
    Profit CAGR
    54.1%

    Computed from filed statements, not filed themselves. A dash means an input was absent, and the score counts only the criteria that could actually be tested.

    Insider trades

    Last 12 months, market trades
    Net buying ₹7.3 Cr
    11 buys · ₹7.3 Cr
    2 sells · ₹0
    Latest insider trades disclosed to NSE
    PersonTypeSharesValueDisclosed
    Abhijit Kishor Rathi
    Gift
    Buy15,000₹02 Apr 2026
    Amit Kishor Rathi
    Immediate relative · Gift
    Buy15,000₹02 Apr 2026
    Leela Kishor Rathi
    Immediate relative · Gift
    Sell45,000₹02 Apr 2026
    Ankit Kishor Rathi
    Gift
    Buy15,000₹02 Apr 2026
    Vasant Rathi
    Promoters · Market Purchase
    Buy18,000₹53.7 L13 Mar 2026
    Vasant Rathi
    Promoters · Market Purchase
    Buy65,000₹1.9 Cr10 Mar 2026
    Vasant Rathi
    Promoters · Market Purchase
    Buy55,000₹1.6 Cr10 Mar 2026
    Vasant Rathi
    Promoters · Market Purchase
    Buy20,000₹59.1 L10 Mar 2026
    Vasant Rathi
    Promoters · Market Purchase
    Buy20,000₹58.2 L9 Feb 2026
    Vasant Rathi
    Promoters · Market Purchase
    Buy37,304₹1.1 Cr7 Feb 2026
    Vasant Rathi
    Promoters · Market Purchase
    Buy21,334₹61.1 L6 Feb 2026
    Vasant Rathi
    Promoters · Market Purchase
    Buy11,362₹32.7 L6 Feb 2026

    Disclosures filed with NSE under SEBI (Prohibition of Insider Trading) Regulations. Pledges and releases are not trades and are not counted above.

    Corporate actions

    • dividend
      ₹1.35

      Dividend - Rs 1.35 Per Share

      24 Jul 2026
      ex-date
    • dividend
      ₹1.20

      Dividend - Rs 1.20 Per Share

      23 Jul 2025
      ex-date
    • dividend
      ₹4.00

      Interim Dividend - Rs 4 Per Share

      16 May 2025
      ex-date
    • dividend
      Not available — not reported in this filing

      Dividend - Re 1.1 Per Share

      18 Jul 2024
      ex-date
    • dividend
      ₹4.00

      Interim Dividend - Rs 4 Per Share

      17 May 2024
      ex-date
    • dividend
      Not available — not reported in this filing

      Dividend - Re 1 Per Share

      4 Aug 2023
      ex-date
    • dividend
      ₹4.00

      Interim Dividend - Rs 4 Per Share

      19 May 2023
      ex-date
    • dividend
      Not available — not reported in this filing

      Dividend - Re 1 Per Share

      11 Aug 2022
      ex-date
    • dividend
      ₹0.90

      Dividend - Rs 0.90 Per Share

      31 Aug 2021
      ex-date
    • dividend
      ₹0.60

      Annual General Meeting/Dividend - Rs 0.60 Per Share

      9 Jul 2020
      ex-date
    • dividend
      ₹0.60

      Annual General Meeting/Dividend - Rs 0.60 Per Share

      1 Aug 2019
      ex-date
    • dividend
      Not available — not reported in this filing

      Annual General Meeting/Dividend Re 0.50 Per Share

      6 Sept 2018
      ex-date
    • dividend
      Not available — not reported in this filing

      Annual General Meeting/Dividend - Re 0.40 Per Share(Book Closure Dates Revised)

      4 Sept 2017
      ex-date
    • split
      Not available — not reported in this filing

      Face Value Split From Rs 10/- Per Share To Rs 2/- Per Share

      25 May 2017
      ex-date
    • other
      Not available — not reported in this filing

      Annual General Meeting

      8 Sept 2016
      ex-date

    Company announcements

    Corp Action
    Announcement under Regulation 30 (LODR)-Daily Buy Back of equity shares

    Daily Report pursuant to Regulation 18(i) of the Buyback Regulations regarding the Equity Shares bought back on October 23, 2026

    Board MeetingPrice-sensitive
    Board Meeting Intimation for The Approval Of Un-Audited Standalone And Consolidated Financial Results For The Quarter And Half Year Ended September 30, 2026

    Advanced Enzyme Technologies Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 31/10/2026 ,inter alia, to consider and approve the Un-Audited ....

    Corp Action
    Announcement under Regulation 30 (LODR)-Daily Buy Back of equity shares

    Daily Report pursuant to Regulation 18(i) of the Buyback Regulations regarding the Equity Shares bought back on October 22, 2026

    Corp Action
    Announcement under Regulation 30 (LODR)-Daily Buy Back of equity shares

    Daily Report pursuant to Regulation 18(i) of the Buyback Regulations regarding the Equity Shares bought back on October 21, 2026

    Others
    Announcement under Regulation 31A (LODR)-(8)(a) Receipt of request

    Intimation of receipt of request from Promoter Group Member for reclassification from Promoter Group Category to Public Category Shareholders under Regulation 31A of the SEBI (Listing Obligations ....

    Others
    Announcement under Regulation 31A (LODR)-(8)(a) Receipt of request

    Intimation of receipt of request from Promoter Group Member for reclassification from Promoter Group Category to Public Category Shareholders under Regulation 31A of the SEBI (Listing Obligations ....

    Corp Action
    Announcement under Regulation 30 (LODR)-Daily Buy Back of equity shares

    Daily Report pursuant to Regulation 18(i) of the Buyback Regulations regarding the Equity Shares bought back on October 19, 2026

    Corp Action
    Announcement under Regulation 30 (LODR)-Daily Buy Back of equity shares

    Daily Report pursuant to Regulation 18(i) of the Buyback Regulation regarding the Equity Shares bought back on October 16, 2026

    Others
    Announcement under Regulation 31A (LODR)-(8)(a) Receipt of request

    Intimation of receipt of request from few Promoter Group Members for reclassification from Promoter Group category to Public Category Shareholders under Regulation 31A of the SEBI (Listing ....

    Corp Action
    Announcement under Regulation 30 (LODR)-Daily Buy Back of equity shares

    Daily Report pursuant to Regulation 18(i) of the Buyback Regulations regarding the Equity Shares bought back on October 15, 2026

    Corp Action
    Announcement under Regulation 30 (LODR)-Daily Buy Back of equity shares

    Daily Report pursuant to Regulation 18(i) of the Buyback Regulations regarding the Equity Shares bought back on October 14, 2026.

    Corp Action
    Announcement under Regulation 30 (LODR)-Daily Buy Back of equity shares

    Daily Report pursuant to Regulation 18(i) of the Buyback Regulations regarding the Equity Shares bought back on October 13, 2026

    Corp Action
    Announcement under Regulation 30 (LODR)-Daily Buy Back of equity shares

    Daily Report pursuant to Regulation 18(i) of the Buyback Regulations regarding the Equity Shares bought back on October 12, 2026.

    Company Update
    Disclosure Under Regulation 31A Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 (As Amended)

    Please find enclosed herewith the intimation of receipt of request from few promoter group members for reclassification from Promoter Group Category to Public Category under Regulation ....

    Corp Action
    Announcement under Regulation 30 (LODR)-Daily Buy Back of equity shares

    Daily Report pursuant to Regulation 18(i) of the Buyback Regulations regarding the Equity Shares bought back on October 09, 2026

    Filed with BSE (scrip 540025); the last 45 days. Documents open at bseindia.com.

    Documents

    Credit ratings

    Documents open at BSE or the rating agency that issued them.

    Sourced from the company's NSE XBRL filing dated 31 Oct 2026 (unaudited). View the source filing. Figures are as filed and are not investment advice.

    FAQ

    Advanced Enzyme Tech: common questions

    Answered from the figures on this page.

    Advanced Enzyme Tech last traded at ₹281.00 (NSE, as of 18 Nov 2026). The last session moved it down 0.76%.

    Advanced Enzyme Tech is valued at about ₹3,031 crore (NSE, as of 18 Nov 2026).

    Advanced Enzyme Tech trades at a price-to-earnings ratio of 18.57 (NSE, as of 18 Nov 2026). The P/E compares the share price with earnings per share, so it is only comparable between companies in the same industry.

    Advanced Enzyme Tech has traded between ₹246.80 and ₹419.00 over the past 52 weeks, to 18 Nov 2026. It is currently 20% of the way up that range.

    Advanced Enzyme Tech (ADVENZYMES) is classified under Pharma on this site's screener.